CardioFocus
PrivateLast Round
Series E
Feb 24, 2023
Total Funding Raised
$221.51M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CardioFocus is a medical device company that specializes in innovative solutions for the precise treatment of atrial fibrillation through a comprehensive system of advanced devices, including a balloon catheter, endoscope, deflectable sheath, and integrated console.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioFocus Comparables
Compare CardioFocus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kardium | 86% | |
| Field Medical | 86% | |
| Adagio Medical | 81% |
CardioFocus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Feb 24, 2023 | ||||
| Series E | Apr 12, 2022 | ||||
| VC Round | Jul 7, 2020 | ||||
| Private Placement | Apr 28, 2020 | ||||
| Series E | May 28, 2019 | ||||
Debt | Jun 22, 2018 |
Key People
Founding team and executive leadership
CardioFocus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kennedy Lewis Investment Management | Private Placement, Series E, VC Round |
| Manatuck Hill Partners | Private Placement, VC Round |
| SV Health Investors | Private Placement, Series E, VC Round, Series C, Series B |
| Fletcher Spaght | Private Placement |
| Accuitive Medical Ventures | Private Placement, Series E, VC Round, Series C |
| Kestrel Venture Management | Private Placement, VC Round, Series B |
| Fletcher Spaght Ventures | Private Placement, Series E, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 39% MoM, reaching 2K.
- Feb 3, 2026
Expanded Pulsed Field Ablation (PFA) clinical programs.
CardioFocus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CardioFocus's valuation, stock price, and market status.
Is CardioFocus a public or private company?
CardioFocus is a private company.
What is the current stock price of CardioFocus?
CardioFocus is a private company with no public stock price. No recent secondary market data is available.
How much is CardioFocus worth (valuation)?
Valuation information for CardioFocus is not publicly available.
Can I buy CardioFocus stock?
CardioFocus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CardioFocus's last funding round?
CardioFocus's most recent funding round was Series E on February 23, 2023.
Who are the main investors in CardioFocus?
Key investors in CardioFocus include SV Health Investors, KBL Healthcare Ventures, H.I.G. Capital.
Will CardioFocus IPO soon?
No public IPO plans have been announced for CardioFocus.
How can I track CardioFocus secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CardioFocus's secondary market activity and sign up for updates.